Presentation is loading. Please wait.

Presentation is loading. Please wait.

2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults by Michael D. Jensen, Donna H. Ryan, Caroline M. Apovian, Jamy D. Ard,

Published byJesse Fletcher Modified over 7 years ago

Similar presentations

Presentation on theme: "2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults by Michael D. Jensen, Donna H. Ryan, Caroline M. Apovian, Jamy D. Ard,"— Presentation transcript:

1 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults by Michael D. Jensen, Donna H. Ryan, Caroline M. Apovian, Jamy D. Ard, Anthony G. Comuzzie, Karen A. Donato, Frank B. Hu, Van S. Hubbard, John M. Jakicic, Robert F. Kushner, Catherine M. Loria, Barbara E. Millen, Cathy A. Nonas, F. Xavier Pi-Sunyer, June Stevens, Victor J. Stevens, Thomas A. Wadden, Bruce M. Wolfe, and Susan Z. Yanovski Circulation Volume 129(25 suppl 2):S102-S138 June 24, 2014 Copyright © American Heart Association, Inc. All rights reserved.

2 Applying Classification of Recommendation and Level of Evidence. Michael D. Jensen et al. Circulation. 2014;129:S102-S138 Copyright © American Heart Association, Inc. All rights reserved.

3 Summary of Recommendations for Obesity. Michael D. Jensen et al. Circulation. 2014;129:S102-S138 Copyright © American Heart Association, Inc. All rights reserved.

4 Treatment Algorithm—Chronic Disease Management Model for Primary Care of Patients With Overweight and Obesity*. *This algorithm applies to the assessment of overweight and obesity and subsequent decisions based on that assessment. Michael D. Jensen et al. Circulation. 2014;129:S102-S138 Copyright © American Heart Association, Inc. All rights reserved.

5 Michael D. Jensen et al. Circulation. 2014;129:S102-S138 Copyright © American Heart Association, Inc. All rights reserved.

6 Michael D. Jensen et al. Circulation. 2014;129:S102-S138 Copyright © American Heart Association, Inc. All rights reserved.

7 Michael D. Jensen et al. Circulation. 2014;129:S102-S138 Copyright © American Heart Association, Inc. All rights reserved.

8 Michael D. Jensen et al. Circulation. 2014;129:S102-S138 Copyright © American Heart Association, Inc. All rights reserved.

9 Michael D. Jensen et al. Circulation. 2014;129:S102-S138 Copyright © American Heart Association, Inc. All rights reserved.

10 Michael D. Jensen et al. Circulation. 2014;129:S102-S138 Copyright © American Heart Association, Inc. All rights reserved.

11 Michael D. Jensen et al. Circulation. 2014;129:S102-S138 Copyright © American Heart Association, Inc. All rights reserved.

12 Michael D. Jensen et al. Circulation. 2014;129:S102-S138 Copyright © American Heart Association, Inc. All rights reserved.

13 Michael D. Jensen et al. Circulation. 2014;129:S102-S138 Copyright © American Heart Association, Inc. All rights reserved.

14 Michael D. Jensen et al. Circulation. 2014;129:S102-S138 Copyright © American Heart Association, Inc. All rights reserved.

15 Michael D. Jensen et al. Circulation. 2014;129:S102-S138 Copyright © American Heart Association, Inc. All rights reserved.

16 Michael D. Jensen et al. Circulation. 2014;129:S102-S138 Copyright © American Heart Association, Inc. All rights reserved.

17 Michael D. Jensen et al. Circulation. 2014;129:S102-S138 Copyright © American Heart Association, Inc. All rights reserved.

18 Michael D. Jensen et al. Circulation. 2014;129:S102-S138 Copyright © American Heart Association, Inc. All rights reserved.

19 Michael D. Jensen et al. Circulation. 2014;129:S102-S138 Copyright © American Heart Association, Inc. All rights reserved.

20 Michael D. Jensen et al. Circulation. 2014;129:S102-S138 Copyright © American Heart Association, Inc. All rights reserved.

21 Michael D. Jensen et al. Circulation. 2014;129:S102-S138 Copyright © American Heart Association, Inc. All rights reserved.

22 Michael D. Jensen et al. Circulation. 2014;129:S102-S138 Copyright © American Heart Association, Inc. All rights reserved.

23 Michael D. Jensen et al. Circulation. 2014;129:S102-S138 Copyright © American Heart Association, Inc. All rights reserved.

24 Michael D. Jensen et al. Circulation. 2014;129:S102-S138 Copyright © American Heart Association, Inc. All rights reserved.

Download ppt "2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults by Michael D. Jensen, Donna H. Ryan, Caroline M. Apovian, Jamy D. Ard,"

Similar presentations

Cardio-Metabolic Syndrome Guidelines on Education, Detection and Early Treatment  Heval Mohamed Kelli, PGY-2 Emory Internal Medicine Residency no conflict.

Cardio-Metabolic Syndrome Guidelines on Education, Detection and Early Treatment  Heval Mohamed Kelli, PGY-2 Emory Internal Medicine Residency no conflict.
Radiographic and Histologic Assessment of Calcium Sulfate in Experimental Animal Models and Clinical Use as a Resorbable Bone-Graft Substitute, a Bone-Graft.

Radiographic and Histologic Assessment of Calcium Sulfate in Experimental Animal Models and Clinical Use as a Resorbable Bone-Graft Substitute, a Bone-Graft.
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults Endorsed by the American Association of Cardiovascular and Pulmonary.

2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults Endorsed by the American Association of Cardiovascular and Pulmonary.
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults NHLBI Obesity Education Initiative National Heart,

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults NHLBI Obesity Education Initiative National Heart,
PALS 2010 algorythems. Copyright ©2010 American Heart Association Kleinman, M. E. et al. Circulation 2010;122:S876-S908 PALS Pulseless Arrest Algorithm.

PALS 2010 algorythems. Copyright ©2010 American Heart Association Kleinman, M. E. et al. Circulation 2010;122:S876-S908 PALS Pulseless Arrest Algorithm.
Phentermine Use in the Obese Patient with IGT – A Case Study Presented by: Ellie R. Hethcox, MSN, ACNP-BC, DNP Student Introduction According to WHO, in.

Phentermine Use in the Obese Patient with IGT – A Case Study Presented by: Ellie R. Hethcox, MSN, ACNP-BC, DNP Student Introduction According to WHO, in.
Trends in Hospitalizations and Outcomes for Acute Cardiovascular Disease and Stroke, 1999–2011CLINICAL PERSPECTIVE by Harlan M. Krumholz, Sharon-Lise T.

Trends in Hospitalizations and Outcomes for Acute Cardiovascular Disease and Stroke, 1999–2011CLINICAL PERSPECTIVE by Harlan M. Krumholz, Sharon-Lise T.
Cumulative Radiation Exposure and Cancer Risk Estimation in Children With Heart DiseaseCLINICAL PERSPECTIVE by Jason N. Johnson, Christoph P. Hornik, Jennifer.

Cumulative Radiation Exposure and Cancer Risk Estimation in Children With Heart DiseaseCLINICAL PERSPECTIVE by Jason N. Johnson, Christoph P. Hornik, Jennifer.
Improved Survival After Out-of-Hospital Cardiac Arrest and Use of Automated External DefibrillatorsCLINICAL PERSPECTIVE by Marieke T. Blom, Stefanie G.

Improved Survival After Out-of-Hospital Cardiac Arrest and Use of Automated External DefibrillatorsCLINICAL PERSPECTIVE by Marieke T. Blom, Stefanie G.
American College of Cardiology/American Heart Association Expert Consensus Document on Electron- Beam Computed Tomography for the Diagnosis and Prognosis.

American College of Cardiology/American Heart Association Expert Consensus Document on Electron- Beam Computed Tomography for the Diagnosis and Prognosis.
Increased Risk for Heart Valve Disease Associated With Antiphospholipid Antibodies in Patients With Systemic Lupus ErythematosusClinical Perspective by.

Increased Risk for Heart Valve Disease Associated With Antiphospholipid Antibodies in Patients With Systemic Lupus ErythematosusClinical Perspective by.
2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and.

2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and.
by , Rita F. Redberg, Emelia J. Benjamin, Vera Bittner, Lynne T

by , Rita F. Redberg, Emelia J. Benjamin, Vera Bittner, Lynne T
Catheter Ablation of Atrial Fibrillation by Roderick Tung, Eric Buch, and Kalyanam Shivkumar Circulation Volume 126(2):223-229 July 10, 2012 Copyright.

Catheter Ablation of Atrial Fibrillation by Roderick Tung, Eric Buch, and Kalyanam Shivkumar Circulation Volume 126(2): July 10, 2012 Copyright.
Bariatric Surgery and Cardiovascular Risk Factors by Paul Poirier, Marc-André Cornier, Theodore Mazzone, Sasha Stiles, Susan Cummings, Samuel Klein, Peter.

Bariatric Surgery and Cardiovascular Risk Factors by Paul Poirier, Marc-André Cornier, Theodore Mazzone, Sasha Stiles, Susan Cummings, Samuel Klein, Peter.
Omega-3 Fatty Acid Blood Levels by H. Robert Superko, Scott M. Superko, Khurram Nasir, Arthur Agatston, and Brenda C. Garrett Circulation Volume 128(19):2154-2161.

Omega-3 Fatty Acid Blood Levels by H. Robert Superko, Scott M. Superko, Khurram Nasir, Arthur Agatston, and Brenda C. Garrett Circulation Volume 128(19):
Guide to the Assessment of Physical Activity: Clinical and Research Applications by Scott J. Strath, Leonard A. Kaminsky, Barbara E. Ainsworth, Ulf Ekelund,

Guide to the Assessment of Physical Activity: Clinical and Research Applications by Scott J. Strath, Leonard A. Kaminsky, Barbara E. Ainsworth, Ulf Ekelund,
Dynamic Changes in Matrix Metalloprotienase Activity Within the Human Myocardial Interstitium During Myocardial Arrest and Reperfusion by Francis G. Spinale,

Dynamic Changes in Matrix Metalloprotienase Activity Within the Human Myocardial Interstitium During Myocardial Arrest and Reperfusion by Francis G. Spinale,
Admission Glucose and Mortality in Elderly Patients Hospitalized With Acute Myocardial Infarction by Mikhail Kosiborod, Saif S. Rathore, Silvio E. Inzucchi,

Admission Glucose and Mortality in Elderly Patients Hospitalized With Acute Myocardial Infarction by Mikhail Kosiborod, Saif S. Rathore, Silvio E. Inzucchi,
Can Adenosine 5′-Triphosphate Be Used to Select Treatment in Severe Vasovagal Syndrome? by Daniel Flammang, Timothy Church, Marc Waynberger, Annick Chassing,

Can Adenosine 5′-Triphosphate Be Used to Select Treatment in Severe Vasovagal Syndrome? by Daniel Flammang, Timothy Church, Marc Waynberger, Annick Chassing,

Similar presentations

Ads by Google